Immungenetics AG is a clinical-stage biopharmaceutical company, developing effective treatments for the devastating diseases of aging: for both, major therapeutic areas as well as orphan/rare indications. Current programs involve neurodegeneration, mitochondrial dysfunctions, metabolic syndromes, autoimmune diseases, inflammation and lifespan. Headquartered in Rostock (Germany) and with labs in Lübeck and Oslo, the company has created three proprietary drug discovery and development platforms which are leading to first-in-class therapies for novel mechanisms of action.
| Website | http://www.immungeneticsag.com |
| Revenue | $5.7 million |
| Employees | View employees |
| Founded | 2009 |
| Address | 23 Gerhart-hauptmann-straße, Rostock, Mecklenburg-Vorpommern 18055, DE |
| Phone | +49 4938 11285224 |
| Industry | Manufacturing General, Drug Discovery, Manufacturing, Pharmaceuticals |
| Competitors | Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, QIAGEN, Bio-Rad Laboratories, MilliporeSigma, PerkinElmer, Inc., BD, Promega Corporation +32 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Immungenetics employee's phone or email?
Immungenetics Questions
The Immungenetics annual revenue was $5.7 million in 2026.
Immungenetics is based in Rostock, Mecklenburg-Vorpommern.
The NAICS codes for Immungenetics are [32541, 3254, 325, 32].
The SIC codes for Immungenetics are [2834, 283, 28].
